Stockholders' Equity - Schedule of Activity Under The Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
Sep. 30, 2026	Dec. 31, 2025
Stockholders' Equity Note [Abstract]
Balance at beginning of period	4,135,501
Options granted	768,254
Options exercised	(706,006)
Options forfeited	(193,816)
Balance at end of period	4,003,933	4,135,501
Options vested and expected to vest as of end of period	4,003,933
Options exercisable at end of period	2,410,370
Balance at beginning of period	$ 8.7
Options granted , Weighted average exercise price	19.03
Options exercised, Weighted average exercise price	5.77
Options forfeited , Weighted average exercise price	15.71
Balance at end of period	10.93	$ 8.7
Weighted-average exercise price, Options vested and expected to vest at end of period	10.93
Weighted-average exercise price, Options exercisable at end of period	$ 7.75
Weighted-average remaining contractual life in years	6 years 10 months 28 days	7 years 4 months 17 days
Weighted-average remaining contractual life in years, Options vested, and expected to vest	6 years 10 months 28 days
Weighted-average remaining contractual life in years, Options exercisable at end of period	6 years 1 month 2 days
Aggregate intrinsic value	$ 53,897	$ 54,842
Aggregate intrinsic value, Options vested and expected to vest at end of period	53,897
Aggregate intrinsic value, Options exercisable at end of period	$ 40,125

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.